Externalizing Behavior Problems and Cigarette Smoking as Predictors of Cannabis Use: The TRAILS Study
Accepted 23 September 2009.
Objective
To examine externalizing behavior problems and cigarette smoking as predictors of subsequent cannabis use.
Method
Dutch adolescents (N = 1,606; 854 girls and 752 boys) from the TRacking Adolescents' Individual Lives Survey (TRAILS) ongoing longitudinal study were examined at baseline (ages 10–12 [T1]) and at two follow-up assessments (ages 12–15 [T2] and 15–18 [T3]). The analysis focused on DSM-IV externalizing behavior (conduct, attention deficit hyperactivity, and oppositional) problems at T1, assessed by the Youth Self Report and the Child Behavior Check List, on self-reported ever smoking at T2, and on cannabis use at T3.
Results
All associations of parent-rated externalizing behavior problems with cannabis were mediated by earlier smoking. Considering self-reported problems, none of these associations with cannabis were mediated by smoking, except the influence of self-reported conduct problems in girls. Interestingly, even after adjusting for externalizing problems, earlier smoking independently and consistently predicted cannabis use. The adjusted odds ratios for smoking varied in boys from 4.8 to 5.2 (ever) from 10 to 12 (daily) and from 22 to 23 (early-onset) whereas in girls from 4.9 to 5.0, 5.6 to 6.1, and 27 to 28, respectively (p <.001 for all).
Conclusions
Our findings challenge the view that externalizing behavior problems directly predict cannabis initiation. Such associations were inconsistent across informants and sexes and were often mediated by earlier smoking. Early smoking onset is a powerful predictor of later cannabis initiation independent of preceding externalizing behavior problems. Although externalizing behavior problems are important as a starting point for substance use trajectories, early-onset smoking should be identified as an important marker of cannabis use risk.
aNational Institute of Health and Welfare & University of Helsinki, Helsinki, Finland
bErasmus Medical Center, Rotterdam, The Netherlands
cUniversity Medical Center Groningen, University of Groningen, Groningen, The Netherlands
dInterdisciplinary Center for Psychiatric Epidemiology (ICPE), University Medical Center Groningen and University of Groningen, The Netherlands, and the Graduate School for Experimental Psychopathology, The Netherlands
Disclosure: Dr. Verhulst is author and head of the department of child and adolescent psychiatry at Erasmus MC, which publishes the Achenbach System of Empirically Based Assessment (ASEBA) and from which he receives remuneration. Drs. Korhonen, Reijneveld, Ormel, and Huizink, and Ms. van Leeuwen report no biomedical financial interests or potential conflict of interest.